Cargando…
Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis
Statin medications act by inhibiting the enzyme hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR), thus decreasing hepatic cholesterol synthesis. They are considered the mainstay treatment of hypercholesterolemia due to their tremendous efficacy and mortality benefit. Although generall...
Autores principales: | Polmann, Michaela B, Suarez, Richard I, Saad, Ali, Bedran, Kebir H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503781/ https://www.ncbi.nlm.nih.gov/pubmed/37719573 http://dx.doi.org/10.7759/cureus.43587 |
Ejemplares similares
-
Statin-Related Necrotizing Autoimmune Myositis: More Than Myalgia
por: Scheuing, William J, et al.
Publicado: (2022) -
A Case of Suspected Statin-Related Delayed Onset Necrotizing Myositis
por: Smirlis, Elias, et al.
Publicado: (2022) -
An Atypical Presentation of Sarcoid Myositis
por: Grubb, Sydney, et al.
Publicado: (2022) -
A Rapidly Debilitating Myopathy: A Rare Case of Statin-Induced Necrotizing Myositis
por: Ahmad, Anam, et al.
Publicado: (2021) -
Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins
por: Salar, Tooba, et al.
Publicado: (2023)